gas gangrene polyvalent antitoxin (equine)
Animal productapproved
Approved
Jul 1, 1949
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1940s
- Jul 1, 1949
Earliest FDA Approval
Indications
Approved for
Mechanism of action
- Clostridium perfringensImmunity, passive
Clostridium perfringens immunity, passive
Approval history
- approvedJul 1, 1949
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gas gangrene polyvalent antitoxin (equine)
- gas gangrene vibrion septique